Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00531453 · FLOW

Participant flow

A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma · Source last updated 2012-01-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    bortezomib, dexamethasone, and thalidomide
    id
    FG000
    title
    Three Drug Regimen (VDT)
  2. description
    bortezomib, dexamethasone, thalidomide, and cyclophosphamide
    id
    FG001
    title
    Four Drug Regimen (VDTC)
periods
  1. milestones
    1. achievements
      1. comment
        02 October 2007
        group Id
        FG000
        num Subjects
        49
      2. comment
        02 October 2007
        group Id
        FG001
        num Subjects
        49
      type
      STARTED
    2. achievements
      1. comment
        10 April 2009
        group Id
        FG000
        num Subjects
        49
      2. comment
        10 April 2009
        group Id
        FG001
        num Subjects
        49
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
All enrolled patients received at least one dose of study drug.
recruitment Details
98 patients were enrolled between October 2007 and September 2008
Complete source fields
groups
  1. description
    bortezomib, dexamethasone, and thalidomide
    id
    FG000
    title
    Three Drug Regimen (VDT)
  2. description
    bortezomib, dexamethasone, thalidomide, and cyclophosphamide
    id
    FG001
    title
    Four Drug Regimen (VDTC)
periods
  1. milestones
    1. achievements
      1. comment
        02 October 2007
        group Id
        FG000
        num Subjects
        49
      2. comment
        02 October 2007
        group Id
        FG001
        num Subjects
        49
      type
      STARTED
    2. achievements
      1. comment
        10 April 2009
        group Id
        FG000
        num Subjects
        49
      2. comment
        10 April 2009
        group Id
        FG001
        num Subjects
        49
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
All enrolled patients received at least one dose of study drug.
recruitment Details
98 patients were enrolled between October 2007 and September 2008

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice